Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login

Urology Journal

  • Home
  • Instant Online
    • Instant 2026
    • Instant 2023
    • Instant 2021
    • Instant 2020
  • Current
  • Archives
  • Announcements
  • Submissions
  • Author Guidelines
  • About
    • About the Journal
    • Editorial Team
    • Privacy Statement
    • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 14 No. 6 (2017): November-December2017
  4. ORIGINAL PAPER(UROLOGICAL ONCOLOGY)

Vol. 14 No. 6 (2017)

November 2017

Association Between Human Papillomavirus and Transitional Cell Carcinoma of the Bladder

  • Pourya Abdollahzadeh
  • Seyed Hamid Madani
  • Sedigheh Khazaei
  • Soraya Sajadimajd
  • Babak Izadi
  • Farid Najafi

Urology Journal, Vol. 14 No. 6 (2017), 4 November 2017 , Page 5047-5050
https://doi.org/10.22037/uj.v14i6.3748 Published: 2017-11-04

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Purpose: Bladder carcinoma is one of the most common malignancies in worldwide. Among several risk factors, Human Papilloma Virus (HPV) have been presumed to play a causative role in the etiology of bladder cell carcinoma. The aim of this study was to evaluate the involvement of HPV infection in biopsy specimens of patients with transitional cell carcinoma at the west of Iran.
Materials and methods: In this study, 97 biopsy specimens including 67 patients with transitional cell carcinoma (TCC) of bladder and 30 cases of control group with the mean age of 63 years were studied using immunohistochemistry to identify HPV.
Results: 22.4% of patients with TCC of bladder and 3.3% of control group were positive for HPV with a meaningful relation (P=.019). The prevalence of HPV was 4.3 fold higher in men than women. Most TCC patients were
belonged to grades II and III.
Conclusion: Considering the higher incidence of HPV positivity in patients with TCC of bladder compared to control group, it seems to be a meaningful association between HPV infection and TCC of bladder, at least in the west of Iran.
  • PDF

How to Cite

Abdollahzadeh, P., Madani, S. H., Khazaei, S., Sajadimajd, S., Izadi, B., & Najafi, F. (2017). Association Between Human Papillomavirus and Transitional Cell Carcinoma of the Bladder. Urology Journal, 14(6), 5047–5050. https://doi.org/10.22037/uj.v14i6.3748
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Oosterlinck W, Lobel B, Jakse G, et al. Guidelines on bladder cancer. Eur Urol. 2002;41:105-12.

Silverberg E. Statistical and epidemiologic data on urologic cancer. Cancer. 1987;60:692-717.

Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374:239-49.

Young R. Usual variants of primary bladder lesions and secondary tumours of the bladder. Pathology of bladder cancer. Baltimore: Williams and Wilkins; 1996:326–37.

Eble JL, Sauter G, Epstein JI. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004: 221-49.

Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234-41.

Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. Jama. 2011;306:737-45.

Noel JC, Thiry L, Verhest A, et al. Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology. 1994;44:671-5.

Youshya S, Purdie K, Breuer J, et al. Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol. 2005;58:207-10.

Wiener JS, Walther PJ. A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types. J Urol. 1994;151:49-53.

zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 1989;49:4677-81.

Gutierrez J, Jimenez A, de Dios Luna J, Soto MJ, Sorlozano A. Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus. J Urol. 2006;176:2474-81; discussion 81.

Griffiths TR, Mellon JK. Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer. BJU Int. 2000;85:211-7.

Shigehara K, Sasagawa T, Kawaguchi S, et al. Prevalence of human papillomavirus infection in the urinary tract of men with urethritis. Int J Urol. 2010;17:563-8.

Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis. 2005;5:102.

Alexander RE, Wang L, Lopez-Beltran A, et al. Human papillomavirus (HPV)-induced neoplasia in the urinary bladder: a missing link? Histol Histopathol. 2016;31:595-600.

Shigehara K, Sasagawa T, Namiki M. Human papillomavirus infection and pathogenesis in urothelial cells: a mini-review. J Infect Chemother. 2014;20:741-7.

De Gaetani C, Ferrari G, Righi E, et al. Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation. J Clin Pathol. 1999;52:103-6.

Shigehara K, Sasagawa T, Kawaguchi S, et al. Etiologic role of human papillomavirus infection in bladder carcinoma. Cancer. 2011;117:2067-76.

Anwar K, Naiki H, Nakakuki K, Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer. 1992;70:1967-73.

Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis. 2011;204:217-23.

Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N, Fujita Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res. 1993;53:4823-7.

Agliano AM, Gradilone A, Gazzaniga P, et al. High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int. 1994;53:125-9.

LaRue H, Simoneau M, Fradet Y. Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res. 1995;1:435-40.

Chen T, Kong Q, Cao H. [The study on relation of human papillomavirus and P53 expression with bladder transitional cell carcinoma]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2000;14:345-8.

Wiwanitkit V. Urinary bladder carcinoma and human papilloma virus infection, an appraisal of risk. Asian Pac J Cancer Prev. 2005;6:217-8.

Kitamura T, Yogo Y, Ueki T, Murakami S, Aso Y. Presence of human papillomavirus type 16 genome in bladder carcinoma in situ of a patient with mild immunodeficiency. Cancer Res. 1988;48:7207-11.

Lopez-Beltran A, Escudero AL, Carrasco-Aznar JC, Vicioso-Recio L. Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization. Pathol Res Pract. 1996;192:154-9.

Yavuzer D, Karadayi N, Salepci T, Baloglu H, Bilici A, Sakirahmet D. Role of human papillomavirus in the development of urothelial carcinoma. Med Oncol. 2011;28:919-23.

Ben Selma W, Ziadi S, Ben Gacem R, et al. Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients. Pathol Res Pract. 2010;206:740-3.

Eslami G, Golshani M, Rakhshon M, Fallah F, Goudarzi H. The study on relation of Human Papillomavirus with bladder transitional cell carcinoma. Cancer Therapy. 2008;6:355-60.

  • Abstract Viewed: 1299 times
  • PDF Downloaded: 865 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus